Sponsor Pipeline

Taizhou Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
1
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
2
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06441344 Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell SCLC Not Yet Recruiting
Phase 2
NCT04813705 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma Recruiting
NCT06319950 High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain… Lung Cancer, Nonsmall Cell Not Yet Recruiting
Not specified
NCT06902935 Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on… Breast Cancer Screening Not Yet Recruiting
NCT07376681 Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring… Prognosis Enrolling by Invitation
Disease Areas
Breast Cancer (2) Lung Cancer (1) Small Cell Lung Cancer (1)
Get alerts when Taizhou Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free